Evidence map›Paper›PMID 25855351›Full record

ArticleParasitology research2015

Laboratory development of permethrin resistance and cross-resistance pattern of Culex quinquefasciatus to other insecticides.

Govindaraju Ramkumar, Muthugoundar S Shivakumar

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Govindaraju RamkumarMolecular Entomology Laboratory, Department of Biotechnology, Periyar University, Salem, Tamil Nadu, India.
Muthugoundar S Shivakumar
Periyar University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance of mosquitoes to insecticides is a growing concern in India. Since only a few insecticides are used for public health and limited development of new molecules is expected in the next decade, maintaining the efficacy of control programs mostly relies on resistance management strategies. Developing such strategies requires a deep understanding of factors influencing resistance together with characterizing the mechanisms involved. Among factors likely to influence insecticide resistance in mosquitoes, agriculture and urbanization have been implicated but rarely studied in detail. In the present study, we evaluate the permethrin resistance and cross-resistance pattern of several insecticides in Culex quinquefasciatus mosquitoes. After 10 generation of selection with permethrin, the LC50 value for both larvae and adult Cx. quinquefasciatus was increased by 17.3- and 17.1-folds compared with susceptible strain. Detoxification enzyme profiles and native PAGE electrophoresis of esterase isoenzyme further revealed that esterase and CytP450 may be involved in permethrin resistance (PerRes) strain compared with susceptible strain. In addition to cross-resistance, study revealed that high resistance to cypermethrin (RR = 6.3, 8.8-folds). This study provided important information for understanding permethrin resistance and facilitating a better strategy for the management of resistance. These studies conclude that a strong foundation for further study of permethrin resistance mechanisms observed in Cx. quinquefasciatus mosquitoes.

Indexed as

Insecticide ResistanceAnimalsCulexIndiaInsecticidesLarvaPermethrinPyrethrinscypermethrinInsecticidesPermethrinPyrethrins

Identifiers

PMID25855351
OpenAlexW2056291875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.